Name: Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine
Brand: reuters.com
SKU: reuters-com-1018
Availability: OnlineOnly

critic

Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine

preview

By The United States and Moderna announced the agreement for 100 million doses of its potential COVID-19 vaccine late on Tuesday.The company’s vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing.The deal confirms Moderna’s experimental vaccine is one of the leading contenders, said BMO analyst George Farmer, who has an “outperform” rating on the stock.With the U.S. contract now signed, other deals could follow, said Jefferies analyst Michael Yee, who has a “buy” rating.“We assume other countries ... will want to secure deals out of sheer responsibility before the capacity of the major 3-4 players is locked up.”Under the contract, Moderna will provide about 100 million doses, with the price coming to around $30.50 per person for a two dose regimen.SVB Leerink analyst Mani Foroohar said the price was lower than deals signed by rivals and pointed to increased competition driving down prices in the coronavirus vaccine market.The U.S. deal would pay out in full if the vaccine achieves certain regulatory milestones before Jan. 31, 2021. ()Reporting by Manas Mishra in Bengaluru; Editing by Anil D’Silva and Shounak DasguptaOur Standards:

By The United States and Moderna announced the agreement for 100 million doses of its potential COVID-19 vaccine late on Tuesday.The company’s vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing.The deal confirms Moderna’s experimental vaccine is one of the leading contenders, said BMO analyst George Farmer, who has an “outperform” rating on the stock.With the U.S. contract now signed, other deals could follow, said Jefferies analyst Michael Yee, who has a “buy” rating.“We assume other countries ... will want to secure deals out of sheer...

public

Correspondent @Reuters. Follow for healthcare/business related news and my obscure interests on your feed.

Manas Mishra

Top and breaking news, pictures and videos from Reuters. For more breaking business news, follow @ReutersBiz.

reuters.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS